Akums Drugs and Pharmaceuticals Limited · AKUMS
Next result 11 Nov 2026 · Q2FY27 (projected)
₹814.65
+1.66% on the day
Close 6 Oct 2026 · 52w ₹414 – ₹823
—scoreno read yet
±5.5%
typical move
on its results, either way
The daily read · from the close of 6 Oct
That day's whole field37.0
score /100rank 616 of 856
chance it trails
Nifty in 10 sessions
Nifty in 10 sessions
In the lower part of the field
Entry reference₹814.65close 6 Oct
Upside reference₹860.31+5.6% · typical 10-session rise
Downside reference₹791.67-2.8% · typical 10-session fall
+8.6% over 30 sessions · +56.9% vs Nifty over 90 · 94% of its 52-week range. Layer percentiles across the field: L2 momentum 94.5, L3 vs market 90.2, L5 own record 6.6. The references are its own median ten-session rise and fall over the past year — arithmetic on its own history, not a price goal.
Its daily score over the last 60 sessions, oldest to newest; green when it sat in the top fifth, red in the bottom fifth. Of the 49 judged, 36 went the way its half of the field leaned.
How it has moved
All performers| Window | Move | vs Nifty | vs sector | vs itself | How it moved | Rank | |
|---|---|---|---|---|---|---|---|
| Week28 Sep on · 6 sessions | -0.6% | +1.0% | — | 35th pct | 2 of 6 up | 287 of 856 | |
| Month1 Sep on · 24 sessions | +4.9% | +10.3% | — | 46th pct | 12 of 24 up | 141 of 856 | |
| Quarter7 Jul on · 64 sessions | +30.4% | +37.2% | — | 83th pct | 33 of 64 up | 70 of 856 | |
| Half year7 Apr on · 125 sessions | +65.1% | +66.0% | — | 95th pct | 68 of 125 up | 96 of 855 | Stretched |
| Year7 Oct on · 246 sessions | +84.6% | +93.8% | — | 99th pct | 127 of 246 up | 59 of 855 | Stretched |
vs itself: where the move sits among this share's own moves of the same length over the past year. Our calculation, not advice.
The read
no read yet
This screen reads a company each morning in the week before its result. Its next result is 11 Nov 2026 (Q2FY27, projected); the read begins about seven days before.
Until then, what its own record says is below: it moves ±5.5% on results on average and was up after ten sessions in 2 of 9.
A read is a position on a screen, not advice. The label says where the composite ranked, the tally says how often that has gone the way it pointed, and the choice is the reader's.
What its results record says
9 results · ten sessions after each · from the close before the result
Up after ten sessions
2 of 9
mean -3.6% · median -2.6%
Best point reached
+0.7%
median · as high as +10.5%
Worst point reached
-4.8%
median · as low as -30.5%
Traded 5% above
2 of 9
closed at least that far up at some point
worst point to best point
where it ended after ten sessions
This is the range each past result travelled, on closing prices. It is a description of the past, not a level for the next one, and this site gives no entry, exit or loss-limit levels.
Intraday · 21 Sep 2026
5-minute candles from 5paisa · 1 session on file → · test patterns →75 five-minute candles · 25 fifteen-minute · hollow body closed above its open, filled body below · hover a candle for its open, high, low and close
Last 90 sessions
daily candles · adjusted for splits and bonuses · test patterns → · the outlook for the coming hours and days → · week by week: slope, patterns, next four weeks →Against the market
same 90 sessions · every line starts at 0%Akums Drugs and Pharmaceuticals LimitedNIFTY 50 (market)
No sector index is mapped for this company, so only the market is shown.
Around the last result · Q1FY27
ten sessions in, the result day, ten sessions out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
After 10 sessions
+10.5%
₹697.45 on 7 Aug → ₹770.35 on 24 Aug
On the result day
+4.7%
close on 10 Aug against the close before
Highest it traded
+12.0%
₹780.85 on 24 Aug · best close +10.5%
Lowest it traded
+0.8%
₹703.00 on 10 Aug · worst close +4.2%
Q4FY26 15 May 2026
-0.6% after 10 · high +4.5% · low -5.3%
Q3FY26 16 Feb 2026
+5.1% after 10 · high +12.1% · low +0.6%
Q2FY26 14 Nov 2025
-2.6% after 10 · high +1.7% · low -5.9%
Ten sessions after each result
share vs market · move from the close before the resultShareNIFTY 50
Results record
move from the close before each result| Quarter | Result day | Gap | T+1 | T+10 | Market T+10 | vs market | vs sector | Vol × | Result |
|---|---|---|---|---|---|---|---|---|---|
| Q1FY27 | 10 Aug 2026 | +1.8% | +9.1% | +10.5% | -1.4% | +11.9% | — | 9.5 | Rev 14% · PAT 56% YoY |
| Q4FY26 | 15 May 2026 | +0.7% | -1.5% | -0.6% | -0.6% | -0.0% | — | 1.8 | — |
| Q3FY26 | 16 Feb 2026 | +2.6% | +8.6% | +5.1% | -2.4% | +7.5% | — | 26.0 | Rev 15% · PAT 2% YoY |
| Q2FY26 | 14 Nov 2025 | -1.7% | +0.7% | -2.6% | +1.3% | -3.9% | — | 6.1 | Rev -2% · PAT -36% YoY |
| Q1FY26 | 11 Aug 2025 | +1.0% | +0.1% | -0.7% | +1.4% | -2.1% | — | 3.3 | Rev 0% · PAT 6% YoY |
| Q4FY25 | 27 May 2025 | +2.3% | -0.9% | -3.0% | +0.4% | -3.5% | — | 7.4 | — |
| Q3FY25 | 7 Feb 2025 | -0.8% | -0.4% | -13.5% | -3.4% | -10.1% | — | 0.9 | — |
| Q2FY25 | 11 Nov 2024 | -0.3% | -19.0% | -19.4% | +0.2% | -19.6% | — | 2.8 | — |
| Q1FY25 | 26 Aug 2024 | +1.7% | -9.0% | -7.8% | +0.5% | -8.2% | — | 0.2 | — |
Reported figures
₹ crore; from the exchange's XBRL filingsRevenue ₹ cr
Net profit ₹ cr
| Quarter | Period end | Revenue | YoY | PAT | YoY | Op. margin | EPS |
|---|---|---|---|---|---|---|---|
| Q1FY27 | 30 Jun 2026 | 1,166 | +13.9% | 100 | +56.1% | 15.0% | 6.53 |
| Q4FY26 | 31 Mar 2026 | 1,157 | — | 81 | — | 12.9% | 5.53 |
| Q3FY26 | 31 Dec 2025 | 1,159 | +14.8% | 67 | +2.1% | 11.1% | 4.33 |
| Q2FY26 | 30 Sep 2025 | 1,017 | -1.5% | 42 | -35.9% | 9.3% | 2.66 |
| Q1FY26 | 30 Jun 2025 | 1,024 | +0.5% | 64 | +5.7% | 12.6% | 4.15 |
| Q3FY25 | 31 Dec 2024 | 1,010 | — | 66 | — | 12.5% | 4.26 |
| Q2FY25 | 30 Sep 2024 | 1,033 | — | 66 | — | 12.1% | 4.37 |
| Q1FY25 | 30 Jun 2024 | 1,019 | — | 61 | — | 12.6% | 4.21 |
Post-mortems
Every result in full →- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- Delivery share rose 6 points in the fortnight before — someone was taking stock home.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Volume ran 1.6x its prior month in the fortnight before.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- No read was made before this result; recorded for the base rate.
- Fell 19% in the 30 sessions before the result — expectations were already low.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Delivery share rose 9 points in the fortnight before — someone was taking stock home.
- No read was made before this result; recorded for the base rate.
- Ran up 30% in the 30 sessions before the result — a good number had little left to reward.
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.
- The market itself moved -3.4% over the same ten sessions; the raw move is mostly tide.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- Delivery share rose 5 points in the fortnight before — someone was taking stock home.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.